307 related articles for article (PubMed ID: 27242373)
1. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
Endo N; Tsuboi N; Furuhashi K; Shi Y; Du Q; Abe T; Hori M; Imaizumi T; Kim H; Katsuno T; Ozaki T; Kosugi T; Matsuo S; Maruyama S
Nephrol Dial Transplant; 2016 Dec; 31(12):2023-2033. PubMed ID: 27242373
[TBL] [Abstract][Full Text] [Related]
2. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
Front Immunol; 2020; 11():671. PubMed ID: 32351512
[TBL] [Abstract][Full Text] [Related]
3. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
Mejia-Vilet JM; Zhang XL; Cruz C; Cano-Verduzco ML; Shapiro JP; Nagaraja HN; Morales-Buenrostro LE; Rovin BH
J Am Soc Nephrol; 2020 Jun; 31(6):1335-1347. PubMed ID: 32300067
[TBL] [Abstract][Full Text] [Related]
4. Urinary Soluble CD163 in Active Renal Vasculitis.
O'Reilly VP; Wong L; Kennedy C; Elliot LA; O'Meachair S; Coughlan AM; O'Brien EC; Ryan MM; Sandoval D; Connolly E; Dekkema GJ; Lau J; Abdulahad WH; Sanders JS; Heeringa P; Buckley C; O'Brien C; Finn S; Cohen CD; Lindemeyer MT; Hickey FB; O'Hara PV; Feighery C; Moran SM; Mellotte G; Clarkson MR; Dorman AJ; Murray PT; Little MA
J Am Soc Nephrol; 2016 Sep; 27(9):2906-16. PubMed ID: 26940094
[TBL] [Abstract][Full Text] [Related]
5. Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis.
Li J; Liu CH; Xu DL; Gao B
Am J Med Sci; 2015 Nov; 350(5):387-92. PubMed ID: 26379042
[TBL] [Abstract][Full Text] [Related]
6. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
[TBL] [Abstract][Full Text] [Related]
7. Significance of M2 macrophages in glomerulonephritis with crescents.
Li J; Yu YF; Liu CH; Wang CM
Pathol Res Pract; 2017 Sep; 213(9):1215-1220. PubMed ID: 28554749
[TBL] [Abstract][Full Text] [Related]
8. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
Gong S; Jin S; Li Y; Jiang W; Zhang Z; Shen Z; Wang J; Zhou H; Liu X; Xu X; Ding X; Shi Y; Liu H
Front Immunol; 2021; 12():769802. PubMed ID: 35003086
[TBL] [Abstract][Full Text] [Related]
9. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
Gupta R; Yadav A; Aggarwal A
Clin Rheumatol; 2021 Mar; 40(3):941-948. PubMed ID: 32809146
[TBL] [Abstract][Full Text] [Related]
10. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis.
Olmes G; Büttner-Herold M; Ferrazzi F; Distel L; Amann K; Daniel C
Arthritis Res Ther; 2016 Apr; 18():90. PubMed ID: 27091114
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H
Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
[TBL] [Abstract][Full Text] [Related]
12. Complement-mediated M2/M1 macrophage polarization may be involved in crescent formation in lupus nephritis.
Tao J; Zhao J; Qi XM; Wu YG
Int Immunopharmacol; 2021 Dec; 101(Pt A):108278. PubMed ID: 34700131
[TBL] [Abstract][Full Text] [Related]
13. Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China.
Yang G; Guo N; Yin J; Wu J
J Int Med Res; 2021 Nov; 49(11):3000605211049963. PubMed ID: 34755559
[TBL] [Abstract][Full Text] [Related]
14. Macrophage subpopulations in pediatric patients with lupus nephritis and other inflammatory diseases affecting the kidney.
Sandersfeld M; Büttner-Herold M; Ferrazzi F; Amann K; Benz K; Daniel C
Arthritis Res Ther; 2024 Feb; 26(1):46. PubMed ID: 38331818
[TBL] [Abstract][Full Text] [Related]
15. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.
Kitagawa A; Tsuboi N; Yokoe Y; Katsuno T; Ikeuchi H; Kajiyama H; Endo N; Sawa Y; Suwa J; Sugiyama Y; Hachiya A; Mimura T; Hiromura K; Maruyama S
Kidney Int; 2019 Mar; 95(3):680-692. PubMed ID: 30712924
[TBL] [Abstract][Full Text] [Related]
16. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
17. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.
Aendekerk JP; Timmermans SAMEG; Busch MH; Potjewijd J; Heeringa P; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1740-1748. PubMed ID: 33203735
[TBL] [Abstract][Full Text] [Related]
18. Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis.
Huang YJ; Lin CH; Yang HY; Luo SF; Kuo CF
Front Immunol; 2022; 13():935700. PubMed ID: 35911758
[TBL] [Abstract][Full Text] [Related]
19. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
Marks SD; Williams SJ; Tullus K; Sebire NJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
[TBL] [Abstract][Full Text] [Related]
20. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
